RT Book, Section A1 Hunt, William R. A1 Tong, David A1 Stecenko, Arlene A2 McKean, Sylvia C. A2 Ross, John J. A2 Dressler, Daniel D. A2 Scheurer, Danielle B. SR Print(0) ID 1137623287 T1 Cystic Fibrosis T2 Principles and Practice of Hospital Medicine, 2e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9780071843133 LK accessmedicine.mhmedical.com/content.aspx?aid=1137623287 RD 2024/10/04 AB Key Clinical Questions How do mutations in the cystic fibrosis (CF) gene relate to the clinical manifestations of the disease? What criteria help determine when a CF patient should be admitted to the hospital for respiratory complications of the disease? What treatment modalities are most effective in restoring lung function to baseline for CF respiratory exacerbations? Why is CF-related diabetes (CFRD) important to control during acute pulmonary exacerbations as well as at baseline? What are the most effective treatment modalities for the two most common pulmonary complications of CF: massive hemoptysis and pneumothorax?